Emergence of Scedosporium apiospermum in patients with cystic fibrosis

Nagano, Yuriko; Millar, B. Cherie; Goldsmith, Cohn E.; Elborn, J. Stuart; Rendall, Jackie; Moore, John E.
July 2007
Archives of Disease in Childhood;Jul2007, Vol. 92 Issue 7, p607
Academic Journal
The article discusses the emergence of Scedosporium apiospermum, a major fungal agent in patients with cystic fibrosis (CF). The Scedosporium apiospermum is a saprophytic filamentous fungus responsible for widespread human infections that affect all organs of the body. It acts as a major fungal agent of chronic colonization of airways in patients. It is reported that the pathogenicity of the organism in CF is not yet fully established.


Related Articles

  • Allergic bronchopulmonary aspergillosis mimicking lung cancer in a nonasthmatic male patient. Kannan, Arun; Gopalan, Sowmya; Arthur, Preetam // Indian Journal of Allergy Asthma & Immunology;Jul-Dec2016, Vol. 30 Issue 2, p99 

    Presentation of Aspergillus infections of the lung is varied. Allergic bronchopulmonary aspergillosis (ABPA) is one such presentation in which there is hypersensitivity reaction to Aspergillus antigens. It occurs commonly in asthmatics and patients with cystic fibrosis. We report a case of ABPA...

  • Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease.  // British Journal of Hospital Medicine (17508460);Feb2008, Vol. 69 Issue 2, p115 

    The article examines the interactions between secondhand smoke and genes that affect cystic fibrosis lung disease in Great Britain. It aims to determine whether secondhand smoke exposure is associated with lung function and other outcomes in individuals with cystic fibrosis. It concludes that...

  • Reasons for heterogeneous change in LCI in children with cystic fibrosis after antibiotic treatment. Yammine, Sophie; Bigler, Anja; Casaulta, Carmen; Singer, Florian; Latzin, Philipp; Horsley, Alex // Thorax;Feb2014, Vol. 69 Issue 2, p183 

    A letter to the editor and a response from the author of the article is presented titled "Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation" in 2013 issue.

  • An unusual cystic lung lesion. Huang, T-W.; Cheng, Y.L.; Lee, S-C. // Thorax;Nov2008, Vol. 63 Issue 11, p980 

    A quiz about an unusual cystic lung lesion is presented.

  • Highlights from this issue. Andrew Bush; Ian Pavord // Thorax;Oct2011, Vol. 66 Issue 10, pi 

    The article discusses various reports published within the issue on topics including lungs attacks in cystic fibrosis patients, lung transplantation and lung cancer screening.

  • Pharmacists can play key role in control of cystic fibrosis. Gebhart, Fred // Drug Topics;2/9/2004, Vol. 148 Issue 3, p29 

    Reports on the effort of the Cystic Fibrosis Foundation in pushing new guidelines for infection control. Relevance of Web cast for the control of cystic fibrosis; Calls for limiting personal contact between cystic fibrosis patients; Information contained in the infection control guidelines.

  • Correlation between carbon dioxide retention during exercise and the rate of decline of FEV1 in cystic fibrosis. Wat, D. // Thorax;Dec2005, Vol. 60 Issue 12, p1011 

    The article focuses on a study, which assesses the correlation between carbon dioxide retention during exercise and the rate of forced expiratory volume in 1 second in cystic fibrosis (CF). In this study, the change in forced expiratory volume in 1 second of 15 CF patients who retained carbon...

  • Genetic Screening: Triumphs, Problems, and Controversies. Natowicz, Marvin R.; Alper, Joseph S. // Journal of Public Health Policy;Winter1991, Vol. 12 Issue 4, p475 

    As genetic screening becomes more widespread, it becomes increasingly important to analyze the manifold implications of genetic screening programs. This paper characterizes the various types of programs and discusses some of the scientific, ethical, social, and economic issues that arise in...

  • 12th annual North American Cystic Fibrosis Conference. October 15-18, 1998, Montreal, Canada. Cowley, Elizabeth A.; Cowley, E A // Clinical & Investigative Medicine;Feb99, Vol. 22 Issue 1, p26 

    Presents the 12th Annual North American Cystic Fibrosis (CF) Conference in Montreal, Canada, which revealed the latest advances in every aspect of CF disease. Pathogenesis of CF lung disease; Treatment of CF pulmonary disease; Cause of CF.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics